He X - Search Results

1

Cost analysis of S1 and XELOX as adjuvant therapy for gastric cancer.

He J, Wen F, Yin X, Zhang P, Du Z, He X, Zhou Y, Tang R, Li M, Li Q. He J, et al. Among authors: he x. Anticancer Drugs. 2013 Aug;24(7):754-8. doi: 10.1097/CAD.0b013e328361bef2. Anticancer Drugs. 2013. PMID: 23629479

2

Cost-effectiveness analysis of colon cancer treatments from MOSIAC and No. 16968 trials.

Wen F, Yao K, Du ZD, He XF, Zhang PF, Tang RL, Li Q. Wen F, et al. World J Gastroenterol. 2014 Dec 21;20(47):17976-84. doi: 10.3748/wjg.v20.i47.17976. World J Gastroenterol. 2014. PMID: 25548497 Free PMC article.

3

Which is false: oxaliplatin or fluoropyrimidine? An analysis of patients with KRAS wild-type metastatic colorectal cancer treated with first-line epidermal growth factor receptor monoclonal antibody.

Wen F, Tang R, Sang Y, Li M, Hu Q, Du Z, Zhou Y, Zhang P, He X, Li Q. Wen F, et al. Among authors: he x. Cancer Sci. 2013 Oct;104(10):1330-8. doi: 10.1111/cas.12224. Epub 2013 Jul 30. Cancer Sci. 2013. PMID: 23822592 Free PMC article.

4

Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.

Zhou J, Zhao R, Wen F, Zhang P, Tang R, Du Z, He X, Zhang J, Li Q. Zhou J, et al. Among authors: he x. Med Oncol. 2015 Apr;32(4):121. doi: 10.1007/s12032-015-0580-4. Epub 2015 Mar 19. Med Oncol. 2015. PMID: 25788034 Clinical Trial.

5

Cost-effectiveness of sorafenib as a first-line treatment for advanced hepatocellular carcinoma.

Zhang P, Yang Y, Wen F, He X, Tang R, Du Z, Zhou J, Zhang J, Li Q. Zhang P, et al. Among authors: he x. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):853-9. doi: 10.1097/MEG.0000000000000373. Eur J Gastroenterol Hepatol. 2015. PMID: 25919775

6

Factors related to the receipt of adjuvant therapy among patients with gastric cancer in Western China.

He X, Chen W, Tang D, Wen F, Zhang P, Li Q. He X, et al. Eur J Cancer Care (Engl). 2019 May;28(3):e13012. doi: 10.1111/ecc.13012. Epub 2019 Feb 12. Eur J Cancer Care (Engl). 2019. PMID: 30748055

7

Adjuvant Chemoradiotherapy for Gastric Cancer: Efficacy and Cost-Effectiveness Analysis.

Zhang M, Wen F, He X, Zhang W, Hu J, Li Q. Zhang M, et al. Among authors: he x. Front Oncol. 2019 Dec 3;9:1357. doi: 10.3389/fonc.2019.01357. eCollection 2019. Front Oncol. 2019. PMID: 31850233 Free PMC article.

8

Curative-intent radiotherapy in patients with oligometastatic lesions from colorectal cancer: A single-center study.

He X, Zhang P, Li Z, Bi F, Xu F, Wang X, Shen Y, Li Q, Qiu M. He X, et al. Medicine (Baltimore). 2018 Oct;97(40):e12601. doi: 10.1097/MD.0000000000012601. Medicine (Baltimore). 2018. PMID: 30290630 Free PMC article.

9

A rare adolescent case of female pseudohermaphroditism with adrenocortical carcinoma and synchronous teratoma.

He XF, Peng XC, Qiu M. He XF, et al. J Pediatr Hematol Oncol. 2013 Jul;35(5):e183-6. doi: 10.1097/MPH.0b013e318286d112. J Pediatr Hematol Oncol. 2013. PMID: 23528907

10

ParSite is a multicolor DNA labeling system that allows for simultaneous imaging of triple genomic loci in living cells.

He X, Sun Y, Ma H. He X, et al. PLoS Biol. 2025 Jan 24;23(1):e3003009. doi: 10.1371/journal.pbio.3003009. Online ahead of print. PLoS Biol. 2025. PMID: 39854604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,341 results

Search Page

Filters